Muller-Oerlinghausen, B, Berghofer, A, Bauer, M. Bipolar disorder.
2002; 359: 241–7.
Bai, YM, Su, TP, Chen, MH, Chen, TJ, Chang, WH. Risk of developing diabetes mellitus and
hyperlipidemia among patients with bipolar disorder, major depressive
disorder, and schizophrenia: a 10-year nationwide population-based
prospective cohort study. J Affect
Lozano, R, Naghavi, M, Foreman, K, Lim, S, Shibuya, K, Aboyans, V, et al. Global and regional mortality from 235 causes
of death for 20 age groups in 1990 and 2010: a systematic analysis for
the Global Burden of Disease Study 2010.
2012; 380: 2095–128.
Jane-Llopis, E, Matytsina, I. Mental health and alcohol, drugs and tobacco: a
review of the comorbidity between mental disorders and the use of
alcohol, tobacco and illicit drugs. Drug Alcohol
2006; 25: 515–36.
Dreyer, L, Winther, JF, Andersen, A, Pukkala, E. Avoidable cancers in the Nordic countries. Alcohol
consumption. APMIS Suppl
Dreyer, L, Winther, JF, Pukkala, E, Andersen, A. Avoidable cancers in the Nordic countries. Tobacco
smoking. APMIS Suppl
Whitley, E, Batty, GD, Mulheran, PA, Gale, CR, Osborn, DP, Tynelius, P, et al. Psychiatric disorder as a risk factor for
cancer: different analytic strategies produce different
2012; 23: 543–50.
Dalton, SO, Mellemkjaer, L, Olsen, JH, Mortensen, PB, Johansen, C. Depression and cancer risk: a register-based study
of patients hospitalized with affective disorders, Denmark,
1969-1993. Am J Epidemiol
2002; 155: 1088–95.
Beumer, W, Gibney, SM, Drexhage, RC, Pont-Lezica, L, Doorduin, J, Klein, HC, et al. The immune theory of psychiatric diseases: a
key role for activated microglia and circulating
monocytes. J Leukoc Biol
2012; 92: 959–75.
Tsai, SY, Chung, KH, Wu, JY, Kuo, CJ, Lee, HC, Huang, SH. Inflammatory markers and their relationships with
leptin and insulin from acute mania to full remission in bipolar
disorder. J Affect Disord
2012; 136: 110–6.
BarChana, M, Levav, I, Lipshitz, I, Pugachova, I, Kohn, R, Weizman, A, et al. Enhanced cancer risk among patients with
bipolar disorder. J Affect Disord
2008; 108: 43–8.
McGinty, EE, Zhang, Y, Guallar, E, Ford, DE, Steinwachs, D, Dixon, LB, et al. Cancer incidence in a sample of Maryland
residents with serious mental illness. Psychiatr
2012; 63: 714–7.
Chen, YH, Lin, HC. Increased risk of cancer subsequent to severe
depression–a nationwide population-based study. J
2011; 131: 200–6.
Rosenshfir, E, Shemesh, P, Aizenberg, D, Barak, Y. Reduced risk of cancer in patients with bipolar
affective disorder. Neurosci & Med
Liang, JA, Sun, LM, Muo, CH, Sung, FC, Chang, SN, Kao, CH. The analysis of depression and subsequent cancer
risk in Taiwan. Cancer Epidemiol Biomarkers
2011; 20: 473–5.
Possel, P, Adams, E, Valentine, JC. Depression as a risk factor for breast cancer:
investigating methodological limitations in the
literature. Cancer Causes Control
2012; 23: 1223–9.
Tsai, SY, Yang, YY, Kuo, CJ, Chen, CC, Leu, SJ. Effects of symptomatic severity on elevation of
plasma soluble interleukin-2 receptor in bipolar mania.
J Affect Disord
2001; 64: 185–93.
Hsieh, MH, Tang, CH, Hung, ST, Lee, IH, Lin, YJ, Yang, YK. Comorbid prevalence of alcohol dependence, substance
abuse, and external cause of injury in patients with bipolar disorder in
a nationwide representative sample in Taiwan.
2012; 14: 677–9.
Bai, YM, Lin, CC, Hu, PG, Yeh, HS. Risk factors for substance use disorders among
inpatients with major affective disorders in Taiwan
Chinese. Gen Hosp Psychiatry
1998; 20: 377–80.
Gau, SS, Chao, PF, Lin, YJ, Chang, CJ, Gau, CS. The association between carbamazepine and valproate
and adverse cutaneous drug reactions in patients with bipolar disorder: a
nested matched case-control study. J Clin
2008; 28: 509–17.
World Health Organization. International
Statistical Classification of Diseases and Related Health Problems
IARC Working Group on the Evaluation of Carcinogenic Risks to
Humans. Tobacco smoke and involuntary
smoking. IARC Monogr Eval Carcinog Risks
Baan, R, Straif, K, Grosse, Y, Secretan, B, El Ghissassi, F, Bouvard, V, et al. Carcinogenicity of alcoholic
beverages. Lancet Oncol
2007; 8: 292–3.
IARC Working Group on the Evaluation of Carcinogenic Risks to
Humans. Alcohol consumption and ethyl
carbamate. IARC Monogr Eval Carcinog Risks
Woo, HD, Kim, J. Dietary flavonoid intake and smoking-related cancer
risk: a meta-analysis. PLoS One
Rothman, KJ, Greenland, S. Modern Epidemiology (2nd edn).
Lippincott Williams & Wilkins,
Tang, CH, Hsieh, MH, Hung, ST, Lee, IH, Lin, YJ, Yang, YK. One-year post-hospital medical costs and relapse
rates of bipolar disorder patients in Taiwan: a population-based
study. Bipolar Disord
2010; 12: 859–65.
Vuorilehto, MS, Melartin, TK, Isometsa, ET. Course and outcome of depressive disorders in
primary care: a prospective 18-month study.
2009; 39: 1697–707.
Heffner, JL, Strawn, JR, DelBello, MP, Strakowski, SM, Anthenelli, RM. The co?occurrence of cigarette smoking and bipolar
disorder: phenomenology and treatment considerations.
2011; 13: 439–53.
Lasser, K, Boyd, JW, Woolhandler, S, Himmelstein, DU, McCormick, D, Bor, DH. Smoking and mental illness.
2000; 284: 2606–10.
Conway, KP, Compton, W, Stinson, FS, Grant, BF. Lifetime comorbidity of DSM-IV mood and anxiety
disorders and specific drug use disorders: results from the National
Epidemiologic Survey on Alcohol and Related Conditions.
J Clin Psychiatry
2006; 67: 247–57.
Wang, PW, Lin, HC, Yeh, YC, Liu, TL, Yen, CF. The relation of substance use with different levels
of depressive symptoms and the moderating effect of sex and age in
Taiwanese adolescents. Compr Psychiatry
2012; 53: 1013–20.
Oerlemans, ME, van den Akker, M, Schuurman, AG, Kellen, E, Buntinx, F. A meta-analysis on depression and subsequent cancer
risk. Clin Pract Epidemiol Ment Health
2007; 3: 29.
Horwath, E, Weissman, MM. Epidemiology of depression and anxiety
disorders. In Textbook in Psychiatric
Epidemiology (eds Tsuang, MT, Tohen, M and Zahner, GEP): 317–44. Wiley-Liss,
Catts, V, Catts, S, O'toole, B, Frost, A. Cancer incidence in patients with schizophrenia and
their first?degree relatives–a meta?analysis.
Acta Psychiatr Scand
2008; 117: 323–36.
Lichtermann, D, Ekelund, J, Pukkala, E, Tanskanen, A, Lonnqvist, J. Incidence of cancer among persons with schizophrenia
and their relatives. Arch Gen Psychiatry
2001; 58: 573.
Barak, Y, Achiron, A, Mandel, M, Mirecki, I, Aizenberg, D. Reduced cancer incidence among patients with
2005; 104: 2817–21.
Hippisley-Cox, J, Vinogradova, Y, Coupland, C, Parker, C. Risk of malignancy in patients with schizophrenia or
bipolar disorder: nested case-control study. Arch
2007; 64: 1368–76.
Lin, GM, Chen, YJ, Kuo, DJ, Jaiteh, LE, Wu, YC, Lo, TS, et al. Cancer incidence in patients with
schizophrenia or bipolar disorder: a nationwide population-based study in
Taiwan, 1997–2009. Schizophr Bull
2013; 39: 407–16.
Chen, YJ, Wu, CY, Chen, TJ, Shen, JL, Chu, SY, Wang, CB, et al. The risk of cancer in patients with
psoriasis: a population-based cohort study in Taiwan.
J Am Acad Dermatol